Vitamin K: Calcium Metabolism Modulator for Menopausal Women

키워드

참고문헌 (92)

1. Shearer MJ, "Metabolism and cell biology of vitamin K", Thromb Haemost, 100, pp.530~547 (2008)
2. Oldenburg J, "The vitamin K cycle", Vitam Horm, 78, pp.35~62 (2008)
3. Halder M, "Vitamin K : double bonds beyond coagulation insights into differences between vitamin K1 and K2 in health and disease", Int J Mol Sci, 20, pp.896~ (2019)
4. Booth SL, "Roles for vitamin K beyond coagulation", Annu Rev Nutr, 29, pp.89~110 (2009)
5. El Asmar MS, "Vitamin k dependent proteins and the role of vitamin k2 in the modulation of vascular calcification : a review", Oman Med J, 29, pp.172~177 (2014)
6. Mandatori D, "The dual role of vitamin K2 in"bone-vascular crosstalk" : opposite effects on bone loss and vascular calcification", Nutrients, 13, pp.1222~ (2021)
7. Willems BA, "The realm of vitamin K dependent proteins : shifting from coagulation toward calcification", Mol Nutr Food Res, 58, pp.1620~1635 (2014)
8. Berkner KL, "Vitamin K-dependent protein activation : normal gamma-glutamyl carboxylation and disruption in disease", Int J Mol Sci, 23, pp.5759~ (2022)
9. Proudfoot D, "Molecular mechanisms mediating vascular calcification : role of matrix Gla protein", Nephrology (Carlton), 11, pp.455~461 (2006)
10. Schurgers LJ, "Matrix Gla-protein : the calcification inhibitor in need of vitamin K", Thromb Haemost, 100, pp.593~603 (2008)
11. Shao JS, "Molecular mechanisms of vascular calcification : lessons learned from the aorta", Arterioscler Thromb Vasc Biol, 26, pp.1423~1430 (2006)
12. Mori K, "Correlation between fetuin-A and matrix Gla protein levels in human serum", Artery Res, 4, pp.91~93 (2010)
13. Shea MK, "Concepts and controversies in evaluating vitamin K status in population-based studies", Nutrients, 8, pp.8~ (2016)
14. Wen L, "Vitamin K‑dependent proteins involved in bone and cardiovascular health(Review)", Mol Med Rep, 18, pp.3~15 (2018)
15. Otani T, "Signaling pathway for adiponectin expression in adipocytes by osteocalcin", Cell Signal, 27, pp.532~544 (2015)
16. Laurance S, "Growth arrest-specific gene 6(gas6)and vascular hemostasis", Adv Nutr, 3, pp.196~203 (2012)
17. Qiu C, "Vitamin K2inhibits rat vascular smooth muscle cell calcification by restoring the Gas6", Axl, Mol Cell Biochem, pp.2017, 433[DOI]
18. Shanahan CM, "Arterial calcification in chronic kidney disease : key roles for calcium and phosphate", Circ Res, 109, pp.697~711 (2011)
19. Mandatori D, "Osteogenic transdifferentiation of vascular smooth muscle cells isolated from spontaneously hypertensive rats and potential menaquinone-4 inhibiting effect", J Cell Physiol, 234, pp.19761~19773 (2019)
20. Beulens JW, "High dietary menaquinone intake is associated with reduced coronary calcification", Atherosclerosis, 203, pp.489~493 (2009)
21. Geleijnse JM, "Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease : the Rotterdam Study", J Nutr, 134, pp.3100~3105 (2004)
22. Gast GC, "A high menaquinone intake reduces the incidence of coronary heart disease", Nutr Metab Cardiovasc Dis, 19, pp.504~510 (2009)
23. Haugsgjerd TR, "Association of dietary vitamin K and risk of coronary heart disease in middle-age adults : the Hordaland Health Study Cohort", BMJ Open, 10, pp.e035953~ (2020)
24. Knapen MH, "Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial", Thromb Haemost, 113, pp.1135~1144 (2015)
25. Braam LA, "Beneficial effects of vitamins D and K on the elastic properties of the vessel wall in postmenopausal women : a followup study", Thromb Haemost, 91, pp.373~380 (2004)
26. Kidd PM, "Vitamins D and K as pleiotropic nutrients : clinical importance to the skeletal and cardiovascular systems and preliminary evidence for synergy", Altern Med Rev, 15, pp.199~222 (2010)
27. Lieben L, "Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization", J Clin Invest, 122, pp.1803~1815 (2012)
28. Manson JE, "Vitamin D supplements and prevention of cancer and cardiovascular disease", N Engl J Med, 380, pp.33~44 (2019)
29. Razzaque MS, "The dualistic role of vitamin D in vascular calcifications", Kidney Int, 79, pp.708~714 (2011)
30. Je SH, "Vitamin K supplement along with vitamin D and calcium reduced serum concentration of undercarboxylated osteocalcin while increasing bone mineral density in Korean postmenopausal women over sixty-years-old", J Korean Med Sci, 26, pp.1093~1098 (2011)
31. Cheng CH, "Osteoporosis due to hormone imbalance : an overview of the effects of estrogen deficiency and glucocorticoid overuse on bone turnover", Int J Mol Sci, 23, pp.1376~ (2022)
32. Lupsa BC, "Bone health and osteoporosis", Endocrinol Metab Clin North Am, 44, pp.517~530 (2015)
33. Aspray TJ, "Osteoporosis and the ageing skeleton", Subcell Biochem, 91, pp.453~476 (2019)
34. Shao JS, "Inflammation and the osteogenic regulation of vascular calcification : a review and perspective", Hypertension, 55, pp.579~592 (2010)
35. Rennenberg RJ, "Vascular calcifications as a marker of increased cardiovascular risk : a meta-analysis", Vasc Health Risk Manag, 5, pp.185~197 (2009)
36. Lampropoulos CE, "Osteoporosis and vascular calcification in postmenopausal women : a cross-sectional study", Climacteric, 19, pp.303~307 (2016)
37. García-Gómez MC, "Osteoporosis and vascular calcification : a shared scenario", Clin Investig Arterioscler, 32, pp.33~42 (2020)
38. Hofbauer LC, "Vascular calcification and osteoporosis—from clinical observation towards molecular understanding", Osteoporos Int, 18, pp.251~259 (2007)
39. Sprini D, "Correlation between osteoporosis and cardiovascular disease", Clin Cases Miner Bone Metab, 11, pp.117~119 (2014)
40. Lampropoulos CE, "Osteoporosis—a risk factor for cardiovascular disease?", Nat Rev Rheumatol, 8, pp.587~598 (2012)
41. London GM, "Bone-vascular cross-talk", J Nephrol, 25, pp.619~625 (2012)
42. Hyder JA, "Association of coronary artery and aortic calcium with lumbar bone density : the MESA Abdominal Aortic Calcium Study", Am J Epidemiol, 169, pp.186~194 (2009)
43. Campos-Obando N, "Bone health and coronary artery calcification : the Rotterdam Study", Atherosclerosis, 241, pp.278~283 (2015)
44. Greendale GA, "Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort : results from the Study of Women’s Health Across the Nation(SWAN)", J Bone Miner Res, 27, pp.111~118 (2012)
45. Kiel DP, "Bone loss and the progression of abdominal aortic calcification over a 25 year period : the Framingham Heart Study", Calcif Tissue Int, 68, pp.271~276 (2001)
46. Persy V, "Vascular calcification and bone disease : the calcification paradox", Trends Mol Med, 15, pp.405~416 (2009)
47. Hamidi MS, "Vitamin K and bone health", J Clin Densitom, 16, pp.409~413 (2013)
48. Zoch ML, "New insights into the biology of osteocalcin", Bone, 82, pp.42~49 (2016)
49. Ducy P, "Increased bone formation in osteocalcin-deficient mice", Nature, 382, pp.448~452 (1996)
50. Morris HA, "Clinical usefulness of bone turnover marker concentrations in osteoporosis", Clin Chim Acta, 467, pp.34~41 (2017)
51. Mott A, "Effect of vitamin K on bone mineral density and fractures in adults : an updated systematic review and meta-analysis of randomised controlled trials", Osteoporos Int, 30, pp.1543~1559 (2019)
52. Tsugawa N, "Vitamin K nutrition and bone health", Nutrients, 12, pp.1909~ (2020)
53. Rangel LBA, "Vitamin K supplementation modulates bone metabolism and ultra-structure of ovariectomized mice", Cell Physiol Biochem, 51, pp.356~374 (2018)
54. Weng SJ, "Effects of combined menaquinone-4 and PTH(1-34)treatment on osetogenesis and angiogenesis in calvarial defect in osteopenic rats", Endocrine, 63, pp.376~384 (2019)
55. Akbari S, "Vitamin K and bone metabolism : a review of the latest evidence in preclinical studies", Biomed Res Int, 2018, pp.4629383~ (2018)
56. Zhang J, "Matrix Gla protein promotes the bone formation by up-regulating Wnt", β-catenin signaling pathway, 2019, pp.10, 891~
57. Mandatori D, "Menaquinone-4 enhances osteogenic potential of human amniotic fluid mesenchymal stem cells cultured in 2D and 3D dynamic culture systems", J Tissue Eng Regen Med, 12, pp.447~459 (2018)
58. Kanellakis S, "Changes in parameters of bone metabolism in postmenopausal women following a 12-month intervention period using dairy products enriched with calcium, vitamin D, and phylloquinone(vitamin K(1))or menaquinone-7(vitamin K(2)) : the Postmenopausal Health Study II", Calcif Tissue Int, 90, pp.251~262 (2012)
59. Knapen MH, "Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women", Osteoporos Int, 24, pp.2499~2507 (2013)
60. Huang ZB, "Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women : a meta-analysis of randomized controlled trials", Osteoporos Int, 26, pp.1175~1186 (2015)
61. Ferland G, "Vitamin K and the nervous system : an overview of its actions", Adv Nutr, 3, pp.204~212 (2012)
62. Denisova NA, "Vitamin K and sphingolipid metabolism : evidence to date", Nutr Rev, 63, pp.111~121 (2005)
63. Fricker M, "Neuronal cell death", Physiol Rev, 98, pp.813~880 (2018)
64. Simes DC, "Vitamin K as a diet supplement with impact in human health : current evidence in age-related diseases", Nutrients, 12, pp.138~ (2020)
65. Adams JB, "Effect of a vitamin", mineral supplement on children and adults with autism, 2011, pp.11, 111~
66. Owoeye O, "Neuroprotective potential of Citrullus lanatus seed extract and Vitamin E against mercury chloride intoxication in male rat brain", Afr J Biomed Res, 21, pp.43~49 (2018)
67. Huang SH, "Molecular mechanism of vitamin K2 protection against amyloid-β-induced cytotoxicity", Biomolecules, 11, pp.423~ (2021)
68. Emekli-Alturfan E, "The emerging relationship between vitamin K and neurodegenerative diseases : a review of current evidence", Mol Biol Rep, 50, pp.815~828 (2023)
69. Chae HB, "Current status of liver diseases in Korea : hepatitis B", Korean J Hepatol, 15(Suppl 6), pp.S13~S24 (2009)
70. Mizuta T, "The effect of menatetrenone, a vitamin K2 analog, on disease recurrence and survival in patients with hepatocellular carcinoma after curative treatment : a pilot study", Cancer, 106, pp.867~872 (2006)
71. Hitomi M, "Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo", Int J Oncol, 26, pp.713~720 (2005)
72. Liu W, "Vitamin K2 inhibits the proliferation of HepG2 cells by upregulating the transcription of p21 gene", Hepatol Res, 37, pp.360~365 (2007)
73. Yamamoto T, "Involvement of hepatoma-derived growth factor in the growth inhibition of hepatocellular carcinoma cells by vitamin K(2)", J Gastroenterol, 44, pp.228~235 (2009)
74. Otsuka M, "Vitamin K2 inhibits the growth and invasiveness of hepatocellular carcinoma cells via protein kinase A activation", Hepatology, 40, pp.243~251 (2004)
75. Kaneda M, "Vitamin K2 suppresses malignancy of HuH7 hepatoma cells via inhibition of connexin 43", Cancer Lett, 263, pp.53~60 (2008)
76. Xv F, "Research progress on the anticancer effects of vitamin K2", Oncol Lett, 15, pp.8926~8934 (2018)
77. Li L, "Induction of apoptosis in hepatocellular carcinoma Smmc-7721 cells by vitamin K(2)is associated with p53 and independent of the intrinsic apoptotic pathway", Mol Cell Biochem, 342, pp.125~131 (2010)
78. Ide Y, "Inhibition of matrix metalloproteinase expression by menatetrenone, a vitamin K2 analogue", Oncol Rep, 22, pp.599~604 (2009)
79. Yoshiji H, "Combined treatment of vitamin K2 and angiotensinconverting enzyme inhibitor ameliorates hepatic dysplastic nodule in a patient with liver cirrhosis", World J Gastroenterol, 13, pp.3259~3261 (2007)
80. Lin M, "Vitamin K2-enhanced liver regeneration is associated with oval cell expansion and up-regulation of matrilin-2 expression in 2-AAF", PH rat model, 2014, pp.14, 361~369
81. Bordoloi J, "Gamma-glutamyl carboxylated Gas6 facilitates the prophylactic effect of vitamin K in inhibiting hyperlipidemia-associated inflammatory pathophysiology via arresting MCP-1", ICAM-1 mediated monocytehepatocyte adhesion, 2021, pp.93, 108635~
82. Coperchini F, "The cytokine storm in COVID-19 : an overview of the involvement of the chemokine", chemokine-receptor system, 2020, pp.53, 25~32
83. Iddir M, "Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition : considerations during the COVID-19 crisis", Nutrients, 12, pp.1562~ (2020)
84. Janssen R, "Vitamin K metabolism as the potential missing link between lung damage and thromboembolism in Coronavirus disease 2019", Br J Nutr, 126, pp.191~198 (2021)
85. Dofferhoff ASM, "Reduced vitamin K status as a potentially modifiable risk factor of severe coronavirus disease 2019", Clin Infect Dis, 73, pp.e4039~e4046 (2021)
86. Chin KY, "The relationship between vitamin K and osteoarthritis : a review of current evidence", Nutrients, 12, pp.1208~ (2020)
87. Misra D, "Vitamin K deficiency is associated with incident knee osteoarthritis", Am J Med, 126, pp.243~248 (2013)
88. Shea MK, "The association between vitamin K status and knee osteoarthritis features in older adults: the Health, Aging and Body Composition Study", Osteoarthritis Cartilage, 23, pp.370~378 (2015)
89. McKeown NM, "Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort", Diabetes Care, 27, pp.538~546 (2004)
90. Kumar R, "Effect of phylloquinone supplementation on glucose homeostasis in humans", Am J Clin Nutr, 92, pp.1528~1532 (2010)
91. Beulens JW, "Dietary phylloquinone and menaquinones intakes and risk of type 2 diabetes", Diabetes Care, 33, pp.1699~1705 (2010)
92. Gutierrez Gossweiler A, "Chapter 6 : vitamins and oral health", Monogr Oral Sci, 28, pp.59~67 (2020)

관련 논문AI추천